Initial Study of Rituximab to Treat Primary Biliary Cirrhosis

NCT00364819 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Primary Biliary Cirrhosis

Interventions

DRUG: rituximab

Sponsor

University of California, Davis

Collaborators

[object Object]